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Occasional review
Effects of cigarette smoke on epithelial cells of the
respiratory tract
Janice A Dye, Kenneth B Adler
Chronic inhalation of cigarette smoke is associ-
ated with mucus hypersecretion, mucus pool-
ing, pulmonary connective tissue damage, and
chronic airflow obstruction.
Cigarette smoke has therefore been causally
linked to the development of chronic obstruc-
tive pulmonary disease (either chronic bron-
chitis or emphysema),' increased airway res-
ponsiveness,2 exacerbations of asthma,3
impaired pulmonary immune function,4 and
increased pulmonary infections.5 Cigarette
smoke has also been established as an important
risk factor for lung,6 laryngeal,7 and nasal neo-
plasia.5 Pathogenetic mechanisms related to
smoke-induced respiratory perturbations, how-
ever, are not fully understood.
One cell type in the lung that may play a
major part in the pathogenesis of cigarette
smoke-induced lesions is the airway epithelial
cell. These cells line the lumen of the airways,
and thus are in a unique position to interact
directly with inhaled cigarette smoke. Most
research involving cigarette smoke and airway
epithelial cells has focused on the "target" cell
responses of these cells in relation to their
relatively simple roles in barrier and mucocili-
ary clearance functions. Depending in part on
the chronicity of exposure, certain functions
may be altered - for example, ciliary beating,
mucus secretion. It has recently become appar-
ent, however, that airway epithelial cells may
also act as "effector" cells, playing pivotal roles
in regulation of airway reflexes, immunological
and inflammatory responses, and maintenance
of bronchodilation. As part of their overall
response to chronic insult these cells are capable
of producing and/or releasing a number of
inflammatory mediators, or undergoing altera-
tions in expression of cell adhesion molecules -
processes that may initiate or perpetuate airway
inflammation.9 To date the influence of cigar-
ette smoke on effector functions of epithelial
cells has yet to be investigated in detail.
Much of the information presented herein is
based on acute in vitro cigarette smoke expos-
ures of epithelial cell cultures or airway
explants, and on relatively acute human or
laboratory animal exposures. Thus, non-neo-
plastic and non-emphysematous end points of
respiratory disease have been emphasised.
Nevertheless, early events in the response to
cigarette smoke or its components may be criti-
cal, and certainly an understanding of these
events may help to elucidate the pathogenetic
mechanisms of many chronic respiratory dis-
eases.
Components of cigarette smoke
Chemical analytical studies have identified over
3800 compounds in tobacco smoke.'" Main-
stream cigarette smoke is composed of a com-
plex mixture of gases and condensed tar par-
ticles. In experimental studies cigarette smoke
is often separated into two phases by a glass
fibre filter that retains nearly all particulate
matter greater than 01 ptm in diameter. The
retained particulate matter is commonly
referred to as the "tar" phase, while the mater-
ial passing through the filter is referred to as the
"gas" phase. Known toxins and carcinogens
have been identified in both the gaseous and
particulate phases." Sidestream smoke (smoke
emitted from the burning tip of the cigarette) is
the major constituent of environmental tobacco
smoke. The chemical composition and gas-to-
particle associations of environmental tobacco
smoke may be different from that of main-
stream smoke, owing to prolonged time and
cooling in the air.'2 Sidestream cigarette smoke
emissions contain carbon monoxide, ammonia,
formaldehyde, benzene, nicotine, acrolein, var-
ious gases and particles, and an assortment of
potentially genotoxic and/or carcinogenic or-
ganic compounds.'3 Increased pulmonary parti-
culate burden due to cigarette smoke may also
play a part in respiratory disease.'4 Recent epi-
demiological findings have indicated adverse
effects of particulate air pollutants at concentra-
tions below currently permissible levels.'5 Res-
pirable suspended particles in indoor air in
homes may increase from approximately 30 jtg/
m3 to greater than 60 jg/M3 due to accumulation
of environmental tobacco smoke.'6
The reported effects of "cigarette smoke"
may include that of mainstream smoke, variably
aged environmental tobacco smoke/sidestream
and exhaled smoke, gaseous phase components
only, particulate phase components only, or
individual chemical compounds such as acro-
lein,'7 acetaldehyde,'5 or formaldehyde.'9 Some
studies have used aqueous extracts of cigarette
smoke obtained by bubbling the smoke through
a buffer, with or without filtering to remove
suspended particulates,20 while other
researchers have focused on free radical pro-
duction arising from chemical reactions within
the cigarette smoke.2'
Overall, owing to the variability in experi-
mental methodologies (including the type of
"cigarette smoke") used, interstudy compari-
sons may be difficult to interpret. It is well to




































Component cells of airway epithelium
The airway epithelium is a mosaic of at least
eight principal cell types, the exact composition
of which may vary depending on the level of the
airway and the species of interest. Ciliated
epithelial cells and goblet cells form most of the
luminal surface of the larger airways, and they
are joined by tight junctions to form a relatively
impermeable barrier to material from the lumi-
nal surface.22 The tight junctions are also im-
portant for polarised secretion and the selective
permeability exhibited by airway epithelium.
Other epithelial cell types (dependent on the
species and airway level) include basal cells,
neuroendocrine cells, Clara cells, serous cells,
small mucous granule cells, brush cells, and a
variety of intermediate cell types.23 The nasal
airways comprise a similar spectrum of cells
together with several unique types required for
olfaction (olfactory sensory and basal cells and
the sustentacular cell).23 Although the effects of
cigarette smoke on nasal airways have been less
extensively studied, significant exposure may
result from nasal exhalation. Moreover, nasal
epithelium is the first respiratory epithelial sur-
face exposed to environmental tobacco smoke.
Airway epithelial surfaces are covered by a
thin layer of mucus consisting of sol and gel
fractions. In addition, mast cells or occasional
lymphocytes are found within the airway epi-
thelium or lumen, although more commonly in
the submucosal layer.22 The epithelium also
contains an abundance of nerve fibres whose
receptors (irritant receptors, stretch receptors)
run circumferentially around the luminal cells
and respond to stimuli such as gases, smoke, or
antigens.22 This review will focus on the epithe-
lial cells that line the luminal surfaces of the
conducting (non-gas exchange) airways. It
should be kept in mind, however, that cigarette
smoke-induced alterations in these cells may
result in altered function of other airway epi-
thelial components. For example, the cigarette
smoke-induced increase in mucosal permea-
bility may also allow increased access of the
epithelial nerve receptors and mast cell popula-
tions to irritant or antigenic stimuli.22
Histological changes in response to
cigarette smoke
Laboratory animals exposed to cigarette smoke
develop histological changes in both the upper
and lower airways (table 1). Hyperplasia and
squamous metaplasia of the respiratory epithe-
lium of the dorsal nasal turbinates was observed
in rats following exposure to sidestream cigar-
Table 1 Histological changes of the respiratory tract
associated with exposure to cigarette smoke
Airway epithelial hyperplasia
Nasal respiratory epithelial hyperplasia
Airway mucous cell hyperplasia
Airway submucosal gland hypertrophy
Intraluminal, mucosal, and parenchymal inflamnmation
Emphysema
Hyperplasia of pulmonary neuroendocrine cells
Reduction of pulmonary lymphoid cells (for example, BALT)
Squamous metaplasia of airway and nasal epithelium
Preneoplastic and neoplastic lesions
ette smoke for 90 days.24 Mice inhaling cigarette
smoke developed basal cell hyperplasia and
squamous metaplasia of the nasal cavity, as well
as hypertrophy of Clara cells.25 In a cigarette
smoke-induced model of "bronchitis" exposure
of Sprague-Dawley rats to smoke (25 cigarettes/
day for 14 days) increased epithelial thickness at
three of the four airway levels assessed due to a
100-400% increase in the number of secretory
cells.26 Initial changes included basal cell pro-
liferation accompanied by mucous metaplasia
of surface epithelial serous cells, and prolifera-
tion of the newly formed mucous cells. The
acidic glycoprotein-containing secretory cells
were dramatically increased in number, while
the neutral glycoprotein-containing secretory
cells were decreased. Histological changes in
airways of patients with chronic bronchitis also
included mucous cell hyperplasia and hyper-
trophy of submucosal glands with a shift to
acidic, sialidase resistant, intracellular glyco-
proteins.
When non-steroidal anti-inflammatory drugs
or corticosteroids were given concurrently with
smoke exposure in a rat model of bronchitis,
smoke-induced mucous cell hyperplasia was
variably inhibited, depending on the drug and
level of the airways examined.27 Additional
studies found that after cigarette smoke expos-
ure in the rats the time required for secretory
cell hyperplasia to resolve was shorter in larger
than smaller airways - for example, trachea nine
days; distal bronchioles up to 84 days.28 Treat-
ment with non-steroidal anti-inflammatory
drugs during the recovery period hastened the
return to normal epithelial architecture in the
smaller airways (to 4-9 days) but had no effect
on tracheal recovery.29 Treatment of rats with
1% N-acetylcysteine during the recovery
period also reduced the time for secretory cell
numbers to return to normal.30 Furthermore,
concurrent administration of N-acetylcysteine
with cigarette smoke exposure inhibited the
initial increase in the number of acidic glyco-
protein-containing secretory cells, but had little
effect on numbers of cells containing neutral
glycoproteins.26
Balansky et alP exposed Sprague-Dawley
rats to cigarette smoke once daily for 40 days
and observed dramatic histological changes in
terminal airways, including severe neutrophilic
infiltration of the mucosa, hyperplastic and
metaplastic lesions, and micropapillomatous
foci. Concurrent administration of N-acetyl-
cysteine effectively prevented these changes.
Studies in humans have also shown signific-
antly increased numbers of total inflammatory
cells and polymorphonuclear leucocytes in
walls of membranous bronchioles in smokers.
This response does not subside following smok-
ing cessation as both current and ex-smokers
had similar numbers and types of inflammatory
cells in their airway walls.'2
Inhaled cigarette smoke also induces pre-
neoplastic changes in rat tracheal epithelial
cells, lesions influenced by dietary deficiencies.
In vitamin A (retinoic acid) deficient rats cigar-
ette smoke caused epidermoid metaplasia char-
acterised by stratified, keratinised, and squa-
mous epithelial changes,3 and focal areas of
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squamous metaplasia including extensive squa-
mous metaplasia of the larynx.34 Conversely,
when neonatal rat tracheas in organ culture
were treated simultaneously with an experi-
mental retinoid compound (Ro 15-0778),
lesions associated with cigarette smoke conden-
sate (hyperplasia, metaplasia, loss of secretory
activity, and ciliary function) were prevented.35
To our knowledge similar studies have not been
performed in humans, although several invest-
igators are evaluating a potential use for retin-
oids in preventing or reversing metaplastic
changes in airway epithelium at the molecular
level. Much of this work has been done with in
vitro models.
Effects of cigarette smoke on epithelial
barrier function
In airway epithelia tight cell-cell and cell-
matrix contact allows for maintenance of a
relatively impermeable (or selectively perme-
able) barrier between the airway lumen and
underlying submucosal and vascular compon-
ents of the respiratory system. Owing in part to
this barrier, specific transport mechanisms of
airway epithelia can regulate chloride secretion
or sodium absorption and precisely maintain
the amount and composition of respiratory tract
lining fluid. Alterations in this fluid occur when
normal airway epithelial function is disrupted
by disease states such as cystic fibrosis, or
exogenously derived perturbation such as cigar-
ette smoking. Although not specific for cigarette
smoking, processes that alter integrity of the
airway epithelium (especially that of the alveo-
lar spaces) are associated with an increased rate
of 99mTc-DTPA clearance. Using 99mTc-DTPA
thoracic scintigraphy has confirmed that lungs
of smokers are more permeable than those of
non-smokers.36 Increased epithelial permea-
bility occurs at an early stage in asymptomatic
or neophyte smokers.37 Rapid clearance is pro-
moted by increased lung volumes and de-
creased surfactant secretion; however, the exact
mechanism(s) for increased 99mTc-DTPA clear-
ance in these states is unknown.38
Cigarette smoke-induced changes in 99mTc-
DTPA clearance could reflect alterations in
permeability of pulmonary vasculature,39 alveo-
lar permeability, and/or altered integrity of the
conducting airways. Cigarette smoke increases
endothelial permeability by its effects on cyto-
skeletal elements as shown in porcine pulmon-
ary artery preparations,. tachykinin release in
rat nasal passageways,' and cation influx in rat
airway vasculature.41 Following cigarette smoke
exposure in guinea pigs changes in alveolar
permeability were associated with type I cell
injury.42 In rabbits acute cigarette smoke expos-
ure was associated with increased 99"Tc-DPTA
clearance, histological focal alveolar oedema
and haemorrhage, but no ultrastructural
changes in the alveolar capillary membrane.43
Increased 99mTc-DPTA clearance occurred in
rats exposed to cigarette smoke, but light mic-
roscopically detectable abnormalities were not
seen in the lung parenchyma.44
Increased permeability of the airway epithe-
lium to large molecular weight molecules (for
example, dextran45) has been demonstrated in
guinea pigs following inhalation of cigarette
smoke, and appeared to be linked to damage to
epithelial tight junctions.46 Bronchial epithelial
cells exhibited increased detachment following
application of proteases to their apical surface
when cultures were first exposed to cigarette
smoke extract (also on their apical surface).47
These results suggest that an intact airway
epithelium is an important barrier against pro-
teases released from intraluminal inflammatory
cells.
Exposure ofprimary hamster tracheal epithe-
lial cells to non-toxic concentrations of cigarette
smoke extract inhibited intercellular communi-
cation across gap junctions.48 In primary chick
embryo hepatocytes cigarette smoke condensate
induced a greater than 60% reduction in gap
junction numbers.49 Furthermore, the number
of gap junctions and the rate of gap junction
communication was inhibited by cigarette
smoke condensate from tobacco-burning, but
not tobacco-heated, cigarettes in cultured rat
hepatic epithelial cells and human fibroblasts.50
Taken together, these studies indicate that
cigarette smoke and/or many of its components
can have a number of deleterious effects on
intercellular communication and epithelial per-
meability. These alterations can play a part in
the development of chronic respiratory dis-
eases.
Alterations in airway secretions and
ciliary clearance apparatus
It is beyond the scope of this report to review
the structure and synthesis ofmucins and struc-
ture and function of cilia. Readers are referred
to several excellent review articles in this area.5'
Briefly, mucociliary clearance is dependent on
the coordinated activities of (a) normal ciliary
structure and function, (b) appropriate quantit-
ies and physicochemical properties of mucus,
and (c) appropriate quantity (depth) of pericili-
ary lining fluid. Alteration or dysfunction ofany
one of these components may result in reduced
efficiency of the entire mucociliary clearance
escalator.52
Cigarette smoke has profound effects on
mucociliary function but the underlying
mechanisms have not been elucidated. Studies
have been hampered by: (a) complex interrela-
tionships between various components of the
mucociliary apparatus; (b) the complexity of the
cigarette smoke mixture; (c) the fact that studies
on the time course of particle clearance depend,
not only on mucociliary velocity, but on initial
particle distribution and deposition patterns;53
and (d) the fact that acute effects of cigarette
smoke in naively exposed subjects do not neces-
sarily reflect those found in chronically exposed
subjects.53 Effects of cigarette smoke on muco-
ciliary function have been reviewed pre-
viously.52
Environmental cigarette smoke exposure has
been implicated increasingly in the develop-
ment of upper respiratory tract infections and
otitis media, especially in children.54 Cigarette
smoke and other indoor air pollutants have been
shown to alter upper airway mucociliary func-
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tion. Nasal mucociliary clearance in asympto-
matic smokers was longer than in lifelong non-
smokers, although no differences were detected
in the mean nasal ciliary beat frequency.55 Con-
versely, acute exposure to cigarette smoke in the
rabbit was associated with increased mucocili-
ary activity of the maxillary sinuses. These
effects, however, were mediated reflexly via
NK1 receptor stimulation by tachykinins
released secondarily to irritant effects of cigar-
ette smoke on sensory afferent nerves in the
upper airways.56
Tracheal mucus from asymptomatic smokers
is increased in both volume and water content,
with a lower total solid content than mucus
from non-smokers. This mucus caused
increased mucociliary "clearability" in frog
palate transport assays.57 Significant elevations
of a macrophage-derived mucus secretagogue
(MMS-68) have been detected in the bron-
choalveolar lavage fluid of cigarette smokers.58
Tracheal potential differences, a measurement
of transepithelial electrical potential difference
used to assess ion permeability and ion trans-
port across respiratory epithelia, were reduced
in chronic cigarette smokers.59
Under similar airway deposition patterns
inner lung zone clearance of particles (as
assessed by gamma camera imaging) was signi-
ficantly slower in asymptomatic smokers than
in age matched non-smoking controls.60 Alveo-
lar deposition after 24 hours, however, was
reduced, suggesting that smokers have a greater
proportion of small conducting airways capable
of mucociliary clearance.6" These findings may
be related to smoking-induced changes in bron-
chiolar secretory cells where secretion of cross-
linked mucus glycoproteins is enhanced,
increasing the efficiency of mucus-cilia coup-
ling. Non-smokers have poorer mucociliary de-
fence capabilities in their more distal peripheral
airways, which would not be necessary unless
chronic insults arose. In these asymptomatic
subjects cigarette smoke-associated alterations
in mucus may be beneficial. Inhalation of
smoke from a single cigarette acutely (and
reversibly) decreased the electrical potential
difference across canine tracheal epithelium.62
Both in vivo and in vitro acute exposure of
cigarette smoke in the dog inhibited active ion
transport (chloride secretion) by tracheal epi-
thelium.62 Chronic smoke exposure in the dog
(10 cigarettes/day for 10 months) caused
persistently increased tracheal mucus flux.63
In vivo and in situ animal studies have been
used to dissect the reflex secretory responses
induced by cigarette smoke. Reflexes initiated
by nervous receptors in the airways normally
augment mucus secretion in response to airway
insult. Absorbed nicotine, however, bypasses
its usual reflex circuits by directly stimulating
ganglion cells.64 In guinea pigs acute inhalation
of low doses of cigarette smoke stimulated air-
way goblet cell secretion by activating choliner-
gic nerves (via parasympathetic ganglion stimu-
lation) whereas exposure to high doses of the
vapour phase of cigarette smoke stimulated
capsaicin-sensitive sensory nerve endings.65 In
rats both control and previously exposed
"bronchitic" animals showed exhibited tran-
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sient increases in fucose (a mucus marker) sec-
retion when cigarette smoke was blown through
their laryngotracheal segments in situ.66 In the
cat in situ studies have indicated the complexity
of reflex responses involved; cigarette smoke
passed directly into the feline trachea segment
stimulated mucin secretion, while smoke passed
directly into the lower airways stimulated secre-
tion in the lung segment. If cigarette smoke was
first passed through the larynx, however, no
augmentation occurred. It seems necessary for
nicotine to be absorbed either directly into the
tracheal segment or into the blood (via the
alveolar spaces) for the autonomic ganglia
innervating the airway submucosal glands to be
stimulated. This reflex pathway predominates
over that of airway irritant reflexes.67
Nicotine was a powerful mucus secretagogue
when applied to ferret tracheal segments in
vitro.68 Exposure of organ cultures of rat tra-
chea to cigarette smoke condensate induced loss
of secretory activity and ciliary function,35 and
exposure of rat tracheal explants to varying
amounts of cigarette smoke for 10 minutes
induced dose-related blebbing of the apical
membrane and loss of cilia.69 The cigarette
smoke component acrolein reduced ciliary beat
frequency in cultured bovine bronchial epithe-
lial cells,70 while acetaldehyde - another major
component of tobacco smoke - impaired ciliary
function and beat frequency by inhibiting cili-
ary dynein ATPase activity and binding to
ciliary proteins critical in the functioning of
dynein and tubulin.7'
Thus, cigarette smoke and/or many of its
components can have direct effects on the secre-
tory and transport functions of airway epithelial
cells. Obviously such alterations can play an
important part in the pathogenesis of chronic
airway disease - for example, decreased muco-
ciliary clearance can result in airway obstruc-
tion and increased susceptibility to microbial
infection.
Influences of cigarette smoke on airway
epithelial regulatory functions
AIRWAY NEUROPEPTIDE REFLEX RESPONSES
AND BRONCHOCONSTRICTION
Airway reflex responses to irritants such as
cigarette smoke are important in mediating
changes in mucus secretion and these pathways
often involve release of tachykinins, a family of
neuropeptides including substance P, neuro-
kinin A, and neurokinin B. When released from
sensory nerve endings in the airways tachy-
kinins act on various receptors eliciting a typical
pattern of response. These collective effects -
often referred to as "neurogenic inflammation"
- include mucus hypersecretion, smooth
muscle contraction, increased airway mucosal
plasma extravasation (associated with increased
vascular permeability), increased neutrophil
adhesion, and cough.72 Tachykinins are nor-
mally rapidly hydrolysed by the membrane-
bound metalloenzyme, neutral endopeptidase
(NEP), which is widely distributed in the air-
ways. Excessive release of tachykinins, how-
ever, decreases the capacity of NEP enzymatic
degradation, or a combination of these effects
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may result in exaggerated neurogenic res-
ponses.
Cigarette smoke exposure stimulated prim-
ary afferent sensory nerves in rats, eliciting
tachykinin release and resultant mucosal
oedema of tracheal tissue.73 Chemical irritants
in the vapour phase of cigarette smoke are
primary elicitors of the permeability response.74
Inhalation of cigarette smoke in guinea pigs also
augments airways responsiveness to inhaled
substance P and capsaicin,74 effects associated
with decreased airway NEP activity.75 Super-
natants from bovine bronchial epithelial cells
exposed to tachykinins exhibited increased neu-
trophil chemotactic activity,76 and direct pre-
treatment of bovine bronchial epithelial cells
with substance P significantly increased adher-
ence of cocultured neutrophils.77
Pulmonary neuroendocrine cells - for ex-
ample, neuroepithelial bodies and small granule
cells - are a poorly understood group of epithe-
lial cells in the airways, and cigarette smoking
has been associated with this hyperplasia and
variable increases in respiratory tract concen-
trations of the bombesin-related peptides.78
Bombesin-related peptides are a family of
neuropeptides similar to amphibian bombesin.
They are present in several human body sys-
tems including the respiratory tract where they
have a role(s) in immunological lung func-
tions.79 They exert chemoattractant activity for
monocytes, mitogenic activity for bronchial
epithelial cells, and bronchoconstrictive activ-
ity. These peptides are involved in cigarette
smoke-associated lung inflammation, fibrosis,
and/or airway obstruction,79 and function as
essential autocrine factors for many small cell
lung cancers. Since cigarette smoke inactivates
NEP, and NEP normally hydrolyses bombesin-
related peptides, it has been proposed that
decreased airway NEP activity may also be
causally related to the development of these
carcinomas.80
Nitric oxide exhibits potent relaxing activity
in both canine and guinea pig airways.8' Unsti-
mulated bovine bronchial epithelial cells in
culture are capable of converting L-arginine to
L-citrulline, one of the biosynthetic pathways of
nitric oxide.82 Moreover, exposure of the epi-
thelial cells to cigarette smoke extract prevented
this conversion, as did treatment of the cells
with competitive inhibitors of nitric oxide syn-
thase.82 Competitive inhibitors of nitric oxide
synthase also decrease ciliary beat frequency in
cultured bronchial epithelial cells,83 and the free
radical reactant product of nitric oxide and low
molecular weight thiols can form S-nitrosothiol
adducts which have potent relaxation effects on
airway smooth muscle.84
Finally, another potential cause of smoke-
induced airway obstruction could be the devel-
opment of airway inflammation and associated
increases in release of cytokines. For example,
guinea pig tracheas cultured with inflammatory
cytokines such as IL-8 and TNFa demon-
strated increased synthesis of endothelin-1, a
potent bronchoconstrictor.85
AIRWAY INFLAMMATION
Perturbations of the airway epithelial cell bar-
rier induced by cigarette smoke may lead to
adverse changes resulting in airway inflamma-
tion (table 2). Specific mechanisms involved in
this inflammation include: (a) increased syn-
thesis and/or release of inflammatory mediators
(for example, arachidonic acid metabolites,
chemotactic agents) or, alternatively, decreased
synthesis of protective mediators (for example,
chemotactic factor inactivators); (b) synthesis of
proinflammatory cytokines; (c) modulation of
cell adhesion molecules; and (d) modulation of
immunoregulatory processes.
Cigarette smoke induces an acute inflamma-
tory reaction in the airways and lung paren-
chyma. Peripheral leucocytosis86 and increases
in bronchoalveolar lavage neutrophil and total
inflammatory cell counts have also been demon-
strated in cigarette smokers.87 In one study both
current and ex-smokers had increased total
inflammatory cells and neutrophils in the walls
of their membranous bronchioles compared
with non-smokers,32 and they also had similar
numbers and types of airway inflammatory cells
present regardless of concurrent emphysema-
tous changes.3288
Airway epithelial cells are an important
source of inflammatory mediators9 since re-
sponses to various stimuli may involve epithe-
lial release of chemotactic activity for leuco-
cytes.89 Cigarette smoke has proved to be a
"reliable" stimulus for inducing release of such
chemotactic activity, although the specific
mediators released vary among species in both
in vivo and in vitro studies. Exposure of young
non-smoking humans to environmental tobacco
smoke for three hours promoted systemic prim-
ing of neutrophils and increased circulating
neutrophil counts, neutrophil chemotaxis, and
neutrophil release of oxidants upon stimula-
tion.90 Similarly, human bronchial epithelial
cell cultures exposed to smoke extract release
significantly greater neutrophil chemotactic ac-
tivity than controls.82 Nitric oxide appeared to
play a part in this response as pretreatment of
the cultures with a nitric oxide synthase inhibi-
tor (L-NMMA) abrogated this increase, while
addition of L-NMMA to supernatants failed to
inhibit neutrophil chemotactic activity.82
At concentrations comparable to levels
observed in the plasma of smokers nicotine
appeared to enhance the neutrophilic response
to other chemotactic peptides.91 At higher con-
centrations, however, nicotine inhibited the
neutrophil chemotactic response and sponta-
Table 2 Potential mechanisms of epithelial cells serving
as effector cells
Neutral endopeptidase enzymatic degradation of tachykinins
Production of bombesin-related peptides
Production of nitric oxide
Production of endothelin-I
Major histocompatibility complex class II antigen expression
Production of arachidonic acid metabolites (for example,
prostaglandins, thromboxanes, leukotrienes,
hydroxyeicosotetraenoic acids)
Production of chemotactic agents
Production of chemotactic factor inactivators
Cytokine production (for example, GM-CSF, G-CSF, IL-6,
IL-8)
Cell adhesion molecule changes (for example, ICAM-1)




neous migration.92 Nicotine pretreatment of
mice appeared to enhance neutrophil influx
towards the "source of inflammation" when the
chemotaxin, zymosan-activated serum, was
injected into the pleural space.92
Smoke-induced recruitment of neutrophils
was complement-dependent in mice: C5-suffi-
cient mice, but not C5-depleted mice, exposed
to cigarette smoke had increased neutrophil
chemotactic activity in their bronchoalveolar
lavage fluids.93 Others suggest that the mechan-
ism of neutrophil influx into the lungs relates to
smoke-induced loss of functional activity of
chemotactic factor inactivator (CFI). CFI nor-
mally inhibits C5a-directed neutrophil chemo-
taxis by binding to GcGlobulin, an essential
cochemotaxin of C5a.94 While specific smoke-
induced effects on other airways or alveoler
protease inhibitors remain largely unknown,
cigarette smoke inactivation of a-protease inhi-
bitor is a contributing factor in the development
of smoking-related emphysema.95
Airway epithelial cells contain both linoleic
acid and arachidonic acid, which are available
for metabolism and release via oxidative path-
ways and are capable of metabolising arachido-
nic acid to prostaglandins, thromboxanes, leuk-
otrienes, and hydroxyeicosotetraenoic acids
(HETEs), although the exact profile of eicosa-
noids is dependent on the species of origin and
the nature of the stimulus - for example, ozone,
nitrogen dioxide.9697 Since these eicosanoids are
associated with effects ranging from enhanced
mucus secretion to smooth muscle contraction
and inflammatory cell chemotaxis their release
following exposure to cigarette smoke has also
been evaluated. In humans cigarette smoking
causes increased urinary excretion of the 2,3-
dinor metabolites of thromboxane A2, but not
prostacyclin (PGI),98 and reduces salivary con-
centrations of PGE2, PGF2,,, leukotrienes, and
12-HETE.99 Bronchoalveolar lavage fluid
obtained from Wistar rats exposed to cigarette
smoke contained increased concentrations of
15-HETE but not thromboxane B2.'00 Conver-
sely, bronchoalveolar lavage fluid from guinea
pigs exposed to acrolein (a low molecular
weight aldehyde found in cigarette smoke) had
increased concentrations of both PGF2,, and
thromboxane B2.'0' In vitro exposure of bovine
tracheal epithelial cells to non-cytotoxic con-
centrations of acrolein caused increased release
of PGE2, PGF2 ,, 6-keto-PGFI,,, 12-HETE, and
15-HETE. Exposure of isolated rat tracheal
segments to cigarette smoke extract elicited a
biphasic effect on muscarinic-stimulated eico-
sanoid synthesis: low concentrations poten-
tiated production while higher concentrations
inhibited this response.'02 Exposure of canine
mast cells to cigarette smoke solution inhibited
PGD2 production but induced increased release
of the preformed mediators, histamine and
tryptase.'03
Research over the last decade has expanded
our knowledge of cytokines and their networks
and their role in inflammatory responses of the
respiratory tract. Airway epithelial cells them-
selves are now known to be capable of synthe-
sising, releasing, and/or upregulating produc-
tion of these locally acting mediators. Analysis
of conditioned medium from human bronchial
epithelial cells in primary culture demonstrated
the presence of GM-CSF, G-CSF, and IL-8.'°4
The presence of GM-CSF and G-CSF in the
conditioned media caused increased in vitro
survival of cultured peripheral blood neutro-
phils.lc4 IL-8 is the major cytokine of the hu-
man nasal epithelium,'05 although conditioned
media from human nasal epithelial cell cultures
also contained GM-CSF, G-CSF, and IL-6.'06
There are too few data available on the influ-
ence of cigarette smoke on cytokine production
by airway epithelial cells, but exposure of hu-
man alveolar epithelial cells to a phenol-rich
glycoprotein present in cigarette smoke con-
densate was associated with increased synthesis
of IL-1 and IL-6. Exposure also elevated
steady state levels of mRNAs for IL-1, IL-6,
and platelet derived growth factor (PDGF-A
and PDGF-B) as detected by in situ nucleic
acid hybridisation.'07 As assessed by bioassays,
cigarette exposure of cultured human and
guinea pig alveolar macrophages decreased IL-
7 and TNF activity.'08 Additionally, lipopoly-
saccharide-stimulated alveolar macrophages
from smokers caused less IL-1 and IL-6
production than alveolar macrophages from
non-smokers.'09 This may be important for the
increased susceptibility of smoking patients to
respiratory infections, and to the decreased
incidence of immune-mediated pulmonary dis-
eases such as sarcoidosis in smokers.' °
Human bronchial epithelial cells have
recently been shown to express the a2-6 integ-
rins, molecules which interact with many extra-
cellular matrix components. Cultured human
respiratory cells also express intercellular adhe-
sion molecule 1 (ICAM-1) on their surfaces.
Adherence of neutrophils to airway epithelial
cells via ICAM-1 may be an important factor in
inflammatory airway diseases."' The processes
by which neutrophils migrate to sites of airway
inflammation are complex and beyond the
scope of this report. Briefly, however, as
reviewed recently,"2 initial steps of neutrophil
recruitment involve a process known as "roll-
ing" whereby neutrophils begin to decelerate
and attach to the endothelial surface of post-
capillary venules at or near sites of tissue injury
or inflammation. Adhesion molecules of the
selectin family (P-, E-, and L-selectin) are
essential components in this process. Neutro-
phils subsequently arrest and spread over the
endothelial cell surface via interactions between
their P2-integrins (CDl la/18 and CDl lb/18)
and endothelial cell ICAM-1. Once firmly
attached, leucocytes migrate through vessel
walls, extracellular matrix components, and
between normally adherent epithelial cells fol-
lowing chemotactic and/or haptotactic gradi-
ents. Migration requires careful regulation of
proteolytic enzyme secretion and transforma-
tion of the cell into a deformable, motile state.
Once near or at the site of airway injury or
inflammation, leucocyte retention involves
critical concentrations of specific cytokine(s) -
for example, GM-CSF - and continued inter-
action with epithelial cell adhesion molecules.
Interestingly enough, proinflammatory cyto-
kines - for example, IL-1, TNFoa - increase cell
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surface expression of ICAM- 1 and neutrophil
adhesion to tracheal epithelial cells in vitro."'
Selective induction of human tracheal ICAM-1
expression in human tracheal epithelial cells has
also been shown in response to interferon y
treatment.
Cigarette smoke elicits a number of neutro-
phil migratory and cell adhesion changes. Neu-
trophil transit time through the human pul-
monary vasculature is prolonged by inhalation
of cigarette smoke."2 Studies in rabbits have
shown that smoking-induced neutrophil reten-
tion in pulmonary vasculature occurs without
corresponding changes in pulmonary haemo-
dynamics."3 In hamsters acute exposure to
mainstream smoke for five minutes provoked
neutrophil rolling and subsequent adhesion to
the endothelium of both postcapillary venules
and arterioles. Adhesion steps were mediated
via 5-lipoxygenase metabolites of arachidonic
acid (leukotrienes)."'4 In vitro exposure of
neutrophils to both the whole particulate and
vapour phase of cigarette smoke reduced the
deformability (hence migratory capability) of
neutrophils via effects on the actin component
of their cytoskeleton."15 Also, plasma myeloper-
oxidase concentrations are elevated immedi-
ately after exposure to cigarette smoke which
suggests that cigarette-induced lung damage is
related to activation of leucocytes still within
the pulmonary capillary bed."3 Further evid-
ence is provided by intravascular neutrophils in
certain lung regions of rabbits exposed to
smoke which showed increased expression of
CD 1 1/CD 18 coincident with decreased L-selec-
tin expression."16 After subacute (two week)
exposure rats did not show altered endothelial
neutrophil adhesion compared with sham-
exposed animals; however, after treatment with
capsaicin they had more vascular adherent neu-
trophils, suggesting that cigarette smoke poten-
tiates neutrophil adhesion in association with
neurogenic airway inflammation. '" Exposure of
monolayers of bovine bronchial epithelial cells
to cigarette smoke extract significantly
increased adherence of both cocultured neutro-
phils and mononuclear cells."8 Peripheral blood
neutrophils exposed to cigarette smoke in vitro
and then cocultured with alveolar epithelial
cells demonstrated decreased adherence which
did not increase after stimulation with
f-Met-Leu-Phe."9
As mentioned previously, cigarette smoking
is associated with a decrease in certain immune
mediated pulmonary diseases"0 while smoking
and/or exposure to environmental tobacco
smoke has been associated with increased res-
piratory infections including sinusitis, otitis
media, bronchitis, and pneumonia,5 conditions
presumably related to alterations in immune
function.'20 Immunological effects induced by
cigarette smoke include reduction of bronchus
associated lymphoid tissue (BALT), decreased
immunoglobulin concentrations due to sup-
pression of B cell antibody production (except
for IgE, which is increased), decreased helper
T cell numbers, decreased natural killer cell
activity, and increased circulating soluble IL-2
receptors.'2012' Infections asociated with cigar-
ette smoke may be related to effects such as
decreased mucociliary clearance of inhaled
infectious agents. Other smoking-related
immunological effects on airway epithelial
function could involve alterations in the expres-
sion of major histocompatibility complex class
II antigen (MHC class II) or alterations in the
function of airway dendritic cells. Expression of
MHC class II antigens was increased in bovine
bronchial epithelial cells exposed to super-
natants from activated lymphocytes.'22 Antigen
presenting functions of pulmonary dendritic
cells (which typically express ICAM-1) are
downregulated via interactions with resident
alveolar macrophages.
Repair of injured areas of airway epithelium
(resulting from either direct cigarette smoke-
induced injury or as a consequence of airway
inflammatory processes) may be impaired by
ongoing cigarette smoke exposure. Cigarette
smoke degrades hyaluronic acid,'23 decreases
fibronectin release from cultured bovine bron-
chial epithelial cells,'24 and delays migration of
bronchial epithelial cells to fibronectin.'25
The airway epithelial cell therefore has the
potential to act as an inflammatory cell, re-
sponding to smoke/and or many of its compon-
ents by releasing a number of humoral and
inflammatory mediators that may enhance the
inflammatory reaction in the airways and con-
tribute to the pathogenesis of chronic disease.
The role of airway epithelial cells as potential
effector cells in the response to smoke or many
other insulting or injurious agents is a research
area that has received much recent attention,
and it is possible that these cells can produce a
number of other as yet unidentified compounds
that can contribute to airway inflammation.
Cigarette smoke combined with other
pulmonary insults
Synergistic effects of cigarette smoke with other
respiratory insults have been reported - for
example, a synergistic effect of asbestos expos-
ure and cigarette smoke in bronchogenic carci-
noma.'26 A mechanism of this synergy suggests
that both deleterious agents provoke generation
of reactive oxygen species in the airways.'27 In
guinea pigs exposure to cigarette smoke com-
bined with intratracheal instillation of amosite
asbestos fibres resulted in increased penetration
of the asbestos fibres into the airway walls.'28
Cigarette smoke exposure also impairs clear-
ance of amosite asbestos fibres (particularly the
shorter fibres) from both alveolar macrophages
(30-fold increase in fibre number) and pulmon-
ary tissue (eightfold increase). 129 Excised rat
tracheal segments exposed to cigarette smoke
followed by amosite asbestos have increased
epithelial uptake of the fibres, and uptake was
still enhanced wher, smoke exposure preceded
asbestos treatment by up to 48 hours.'30 Again,
reactive oxygen species played a part in smoke-
mediated fibre transport into the tracheal epi-
thelium."' Cigarette smoke exposure of tra-
cheal epithelial explants also directly enhanced
uptake of inert dust - that is, non-fibrous
titanium dioxide, talc, and fibrous silicon car-
bide - while treatment with scavengers of reac-
tive oxygen species only blocked uptake of some
of these particles.'32 Finally, exposure to cigar-
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ette smoke has also been associated with poten-
tiation of pulmonary injury following instilla-
tion of bleomycin,133 irradiation-induced
pneumonitis,'34 and ozone inhalation.'35
Conclusions
Cigarette smoke and many of its individual
components, both gaseous and particulate, can
generate various lesions in epithelial cells of the
airways. Interactions between these stimuli and
airway epithelial cells are just beginning to be
elucidated. Although studies of cigarette
smoke-induced effects on individual cells of the
airway epithelium are exceedingly useful for
eliciting underlying mechanisms of respiratory
injury and disease, the overall respiratory sys-
tem response depends ultimately upon the inte-
grated action of all effector cell populations with
their corresponding target cells. To fully
understand how defence mechanisms within
the respiratory system attempt to intervene
against cigarette smoke while attempting to
repair previous smoke-induced damage, these
interactions of airway epithelial cells with other
host defence/repair mechanisms must be more
completely understood.
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